Cambridge NeuroScience data

Cambridge NeuroScience Inc. (CNSI) Cambridge NeuroScience Inc. (CNSI) said it is discontinuing development of Ectapram as an adjunct treatment to electroconvulsive therapy (ECT) after the drug did n...